Regulatory 2021-08-19 | Quarterly Report Q2 2021: Preparing Oncoral for the next level Download Presentation Webcast Excel
Regulatory 2021-05-12 | Quarterly Report Q1 2021: US office opened in preparation of launch Download Presentation Webcast Excel
Regulatory 2021-03-30 | Ascelia Pharma publishes Annual Report for 2020 Download Presentation Webcast Excel
Regulatory 2021-02-16 | Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study Download Presentation Webcast Excel
Regulatory 2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch Download Presentation Webcast Excel
Regulatory 2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study Download Presentation Webcast Excel
Regulatory 2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE Download Presentation Webcast Excel
Regulatory 2020-04-06 | Ascelia Pharma publishes Annual Report for the financial year 2019 Download Presentation Webcast Excel
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE Download Presentation Webcast Excel
Regulatory 2019-11-08 | Preparations for Phase III study with Mangoral[®] on track Download Presentation Webcast Excel
Regulatory 2019-10-14 | Ascelia Pharma publishes Annual Report for the financial year 2018/2019 Download Presentation Webcast Excel
Regulatory 2019-08-22 | Phase III study of Mangoral to start in H2-2019 Download Presentation Webcast Excel
Regulatory 2019-05-15 | Fully financed Phase III program for Mangoral through the IPO Download Presentation Webcast Excel
